Travere Therapeutics, Inc. · NASDAQ:TVTX
Cline Christopher R. sold 50,508 Travere Therapeutics, Inc. shares (Form 4)
Traded Sep 15, 2026 · Filed Sep 17, 2026
On Sep 15, 2026, Cline Christopher R. (CHIEF FINANCIAL OFFICER) sold 50,508 Travere Therapeutics, Inc. shares at an average US$62.34 for US$3.15M under a trading plan, leaving 87,508 shares. Filed Sep 17, 2026 (Form 4).
- Sold
- 50,508 shares
- Price
- US$62.34 average (US$62.00 to US$65.31)
- Value
- US$3.15M
- Holding after
- 87,508 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- CHIEF FINANCIAL OFFICER
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 15, 2026 | Common Stock | Option exercise | 20,000 | US$17.44 | 138,016 | Direct |
| Sep 15, 2026 | Common Stock | Sale | 27,473 | US$62.00 | 110,543 | Direct |
| Sep 15, 2026 | Common Stock | Sale | 20,735 | US$62.61 | 89,808 | Direct |
| Sep 15, 2026 | Common Stock | Sale | 1,900 | US$63.69 | 87,908 | Direct |
| Sep 15, 2026 | Common Stock | Sale | 400 | US$65.31 | 87,508 | Direct |
Source
Related
- Travere Therapeutics, Inc.
- Cline Christopher R.
- Travere Therapeutics, Inc. shareholders
- Form 4 · Cline Christopher R. · Sep 3, 2026
- Form 4 · Cline Christopher R. · May 6, 2026
- Form 4 · Cline Christopher R. · Apr 15, 2026
- Form 4 · Dube Eric M · Oct 19, 2026
- Form 4 · Heerma Peter · Sep 17, 2026
- Form 4 · Dube Eric M · Sep 17, 2026
- Form 4 · Rote William E. · Sep 17, 2026
- Form 4 · Inrig Jula · Sep 17, 2026